US Patent Issued to NORTHRIDGE HEALTH GROUP (HONG KONG) on May 13 for "PTPN2/PTP1B degrader and therapeutic method thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,193, issued on May 13, was assigned to NORTHRIDGE HEALTH GROUP (HONG KONG) Co. Ltd. (Hong Kong).

"PTPN2/PTP1B degrader and therapeutic method thereof" was invented by Lei Han (Hong Kong) and Jinzi Jason Wu (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes a PTPN2/PTP1B degrader compounds having the structure of Formula (I), that are useful for treating PTPN2/PTP1B-mediated disorders or conditions,"

The patent was filed on Oct. 17, 2024, under Application No. 18/918,161.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HIT...